Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Drives Commercialization Strategy with Appointment of Ivan Yifei Zhu as Chief Commercial Officer 2020-07-28 20:22
I-Mab Announces Authorization of Stock Repurchase Program up to $20 Million 2020-07-16 04:15
I-Mab and ABL Bio to Present Preclinical Data for Joint Bispecific Antibody Program at the 2020 American Association for Cancer Research Virtual Meeting II 2020-06-12 20:00
I-Mab Announces Upcoming Participation at June Conferences 2020-05-29 20:00
I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome 2020-05-28 04:05
I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme 2020-05-21 20:00
I-Mab Expands Global Presence with New Hong Kong Office 2020-05-20 16:00
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors 2020-05-13 20:00
1 3 4 5 6 7